Literature DB >> 16373333

HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells.

Xin Zhang1, B Starling Emerald, Svetlana Mukhina, Kumarasamypet M Mohankumar, Astrid Kraemer, Alpha S Yap, Peter D Gluckman, Kok-Onn Lee, Peter E Lobie.   

Abstract

Forced expression of HOXA1 is sufficient to stimulate oncogenic transformation of immortalized human mammary epithelial cells and subsequent tumor formation. We report here that the expression and transcriptional activity of HOXA1 are increased in mammary carcinoma cells at full confluence. This confluence-dependent expression of HOXA1 was abrogated by incubation of cells with EGTA to produce loss of intercellular contact and rescued by extracellular addition of Ca2+. Increased HOXA1 expression at full confluence was prevented by an E-cadherin function-blocking antibody and attachment of non-confluent cells to a substrate by homophilic ligation of E-cadherin increased HOXA1 expression. E-cadherin-directed signaling increased HOXA1 expression through Rac1. Increased HOXA1 expression consequent to E-cadherin-activated signaling decreased apoptotic cell death and was required for E-cadherin-dependent anchorage-independent proliferation of human mammary carcinoma cells. HOXA1 is therefore a downstream effector of E-cadherin-directed signaling required for anchorage-independent proliferation of mammary carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373333     DOI: 10.1074/jbc.M512666200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  The function of homeobox genes and lncRNAs in cancer.

Authors:  Yingchao Wang; Yuan Dang; Jingfeng Liu; Xiaojuan Ouyang
Journal:  Oncol Lett       Date:  2016-07-21       Impact factor: 2.967

3.  Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways.

Authors:  Sabine M Brouxhon; Stephanos Kyrkanides; Xiaofei Teng; Veena Raja; M Kerry O'Banion; Robert Clarke; Stephen Byers; Andrew Silberfeld; Carmen Tornos; Li Ma
Journal:  Clin Cancer Res       Date:  2013-04-25       Impact factor: 12.531

Review 4.  miR-210: the master hypoxamir.

Authors:  Yuk C Chan; Jaideep Banerjee; Sang Yong Choi; Chandan K Sen
Journal:  Microcirculation       Date:  2012-04       Impact factor: 2.628

5.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

6.  Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Tian-Zhou Zha; Ben-Shun Hu; Hai-Feng Yu; Yong-Fei Tan; Yun Zhang; Kai Zhang
Journal:  Tumour Biol       Date:  2012-08-04

7.  Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Authors:  Christine J Ye; Joshua B Stevens; Guo Liu; Steven W Bremer; Aruna S Jaiswal; Karen J Ye; Ming-Fong Lin; Lesley Lawrenson; Wayne D Lancaster; Markku Kurkinen; Joshua D Liao; C Gary Gairola; Malathy P V Shekhar; Satya Narayan; Fred R Miller; Henry H Q Heng
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

8.  The truncated Hoxa1 protein interacts with Hoxa1 and Pbx1 in stem cells.

Authors:  Cristina C Fernandez; Lorraine J Gudas
Journal:  J Cell Biochem       Date:  2009-02-15       Impact factor: 4.429

9.  Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma.

Authors:  Hui Li; Xiaomin Wang; Mingjie Zhang; Mengjun Wang; Junjie Zhang; Shiyin Ma
Journal:  Front Mol Biosci       Date:  2021-03-08

10.  Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.

Authors:  You Me Sung; Xuehua Xu; Junfeng Sun; Duane Mueller; Kinza Sentissi; Peter Johnson; Elana Urbach; Françoise Seillier-Moiseiwitsch; Michael D Johnson; Susette C Mueller
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.